Global mRNA Vaccines and mRNA Drugs Market Growth 2023-2029
The report requires updating with new data and is sent in 106 hours after order is placed.
According to our LPI (LP Information) latest study, the global mRNA Vaccines and mRNA Drugs market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the mRNA Vaccines and mRNA Drugs is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global mRNA Vaccines and mRNA Drugs market. With recovery from influence of COVID-19 and the Russia-Ukraine War, mRNA Vaccines and mRNA Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of mRNA Vaccines and mRNA Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the mRNA Vaccines and mRNA Drugs market.
Key Features:
The report on mRNA Vaccines and mRNA Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the mRNA Vaccines and mRNA Drugs market. It may include historical data, market segmentation by Type (e.g., Vaccine, API), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the mRNA Vaccines and mRNA Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the mRNA Vaccines and mRNA Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the mRNA Vaccines and mRNA Drugs industry. This include advancements in mRNA Vaccines and mRNA Drugs technology, mRNA Vaccines and mRNA Drugs new entrants, mRNA Vaccines and mRNA Drugs new investment, and other innovations that are shaping the future of mRNA Vaccines and mRNA Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the mRNA Vaccines and mRNA Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for mRNA Vaccines and mRNA Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the mRNA Vaccines and mRNA Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting mRNA Vaccines and mRNA Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the mRNA Vaccines and mRNA Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the mRNA Vaccines and mRNA Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the mRNA Vaccines and mRNA Drugs market.
Market Segmentation:
mRNA Vaccines and mRNA Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global mRNA Vaccines and mRNA Drugs market?
What factors are driving mRNA Vaccines and mRNA Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do mRNA Vaccines and mRNA Drugs market opportunities vary by end market size?
How does mRNA Vaccines and mRNA Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
According to our LPI (LP Information) latest study, the global mRNA Vaccines and mRNA Drugs market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the mRNA Vaccines and mRNA Drugs is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global mRNA Vaccines and mRNA Drugs market. With recovery from influence of COVID-19 and the Russia-Ukraine War, mRNA Vaccines and mRNA Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of mRNA Vaccines and mRNA Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the mRNA Vaccines and mRNA Drugs market.
Key Features:
The report on mRNA Vaccines and mRNA Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the mRNA Vaccines and mRNA Drugs market. It may include historical data, market segmentation by Type (e.g., Vaccine, API), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the mRNA Vaccines and mRNA Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the mRNA Vaccines and mRNA Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the mRNA Vaccines and mRNA Drugs industry. This include advancements in mRNA Vaccines and mRNA Drugs technology, mRNA Vaccines and mRNA Drugs new entrants, mRNA Vaccines and mRNA Drugs new investment, and other innovations that are shaping the future of mRNA Vaccines and mRNA Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the mRNA Vaccines and mRNA Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for mRNA Vaccines and mRNA Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the mRNA Vaccines and mRNA Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting mRNA Vaccines and mRNA Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the mRNA Vaccines and mRNA Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the mRNA Vaccines and mRNA Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the mRNA Vaccines and mRNA Drugs market.
Market Segmentation:
mRNA Vaccines and mRNA Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Vaccine
- API
- Infectious Disease
- Cancer
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher
- Merck
- Qiagen N.V.
- CureVac
- In-Cell-Art
- eTheRNA
- Takara Bio Inc.
- Sangamo Therapeutics
- Roche CustomBiotech
- BioNTech
- Tiba Biotechnology
- TriLink Bio Technologies
- Argos Therapeutics
- Moderna Therapeutics
- NEB
- Ethris
- Aldevron
- Promega
- Translate Bio
What is the 10-year outlook for the global mRNA Vaccines and mRNA Drugs market?
What factors are driving mRNA Vaccines and mRNA Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do mRNA Vaccines and mRNA Drugs market opportunities vary by end market size?
How does mRNA Vaccines and mRNA Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Vaccines and mRNA Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for mRNA Vaccines and mRNA Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for mRNA Vaccines and mRNA Drugs by Country/Region, 2018, 2022 & 2029
2.2 mRNA Vaccines and mRNA Drugs Segment by Type
2.2.1 Vaccine
2.2.2 API
2.3 mRNA Vaccines and mRNA Drugs Sales by Type
2.3.1 Global mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global mRNA Vaccines and mRNA Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global mRNA Vaccines and mRNA Drugs Sale Price by Type (2018-2023)
2.4 mRNA Vaccines and mRNA Drugs Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.5 mRNA Vaccines and mRNA Drugs Sales by Application
2.5.1 Global mRNA Vaccines and mRNA Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global mRNA Vaccines and mRNA Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global mRNA Vaccines and mRNA Drugs Sale Price by Application (2018-2023)
3 GLOBAL MRNA VACCINES AND MRNA DRUGS BY COMPANY
3.1 Global mRNA Vaccines and mRNA Drugs Breakdown Data by Company
3.1.1 Global mRNA Vaccines and mRNA Drugs Annual Sales by Company (2018-2023)
3.1.2 Global mRNA Vaccines and mRNA Drugs Sales Market Share by Company (2018-2023)
3.2 Global mRNA Vaccines and mRNA Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global mRNA Vaccines and mRNA Drugs Revenue by Company (2018-2023)
3.2.2 Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Company (2018-2023)
3.3 Global mRNA Vaccines and mRNA Drugs Sale Price by Company
3.4 Key Manufacturers mRNA Vaccines and mRNA Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA Vaccines and mRNA Drugs Product Location Distribution
3.4.2 Players mRNA Vaccines and mRNA Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MRNA VACCINES AND MRNA DRUGS BY GEOGRAPHIC REGION
4.1 World Historic mRNA Vaccines and mRNA Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global mRNA Vaccines and mRNA Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global mRNA Vaccines and mRNA Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic mRNA Vaccines and mRNA Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global mRNA Vaccines and mRNA Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global mRNA Vaccines and mRNA Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas mRNA Vaccines and mRNA Drugs Sales Growth
4.4 APAC mRNA Vaccines and mRNA Drugs Sales Growth
4.5 Europe mRNA Vaccines and mRNA Drugs Sales Growth
4.6 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Growth
5 AMERICAS
5.1 Americas mRNA Vaccines and mRNA Drugs Sales by Country
5.1.1 Americas mRNA Vaccines and mRNA Drugs Sales by Country (2018-2023)
5.1.2 Americas mRNA Vaccines and mRNA Drugs Revenue by Country (2018-2023)
5.2 Americas mRNA Vaccines and mRNA Drugs Sales by Type
5.3 Americas mRNA Vaccines and mRNA Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Vaccines and mRNA Drugs Sales by Region
6.1.1 APAC mRNA Vaccines and mRNA Drugs Sales by Region (2018-2023)
6.1.2 APAC mRNA Vaccines and mRNA Drugs Revenue by Region (2018-2023)
6.2 APAC mRNA Vaccines and mRNA Drugs Sales by Type
6.3 APAC mRNA Vaccines and mRNA Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe mRNA Vaccines and mRNA Drugs by Country
7.1.1 Europe mRNA Vaccines and mRNA Drugs Sales by Country (2018-2023)
7.1.2 Europe mRNA Vaccines and mRNA Drugs Revenue by Country (2018-2023)
7.2 Europe mRNA Vaccines and mRNA Drugs Sales by Type
7.3 Europe mRNA Vaccines and mRNA Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Vaccines and mRNA Drugs by Country
8.1.1 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Type
8.3 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA Vaccines and mRNA Drugs
10.3 Manufacturing Process Analysis of mRNA Vaccines and mRNA Drugs
10.4 Industry Chain Structure of mRNA Vaccines and mRNA Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 mRNA Vaccines and mRNA Drugs Distributors
11.3 mRNA Vaccines and mRNA Drugs Customer
12 WORLD FORECAST REVIEW FOR MRNA VACCINES AND MRNA DRUGS BY GEOGRAPHIC REGION
12.1 Global mRNA Vaccines and mRNA Drugs Market Size Forecast by Region
12.1.1 Global mRNA Vaccines and mRNA Drugs Forecast by Region (2024-2029)
12.1.2 Global mRNA Vaccines and mRNA Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global mRNA Vaccines and mRNA Drugs Forecast by Type
12.7 Global mRNA Vaccines and mRNA Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher
13.1.1 Thermo Fisher Company Information
13.1.2 Thermo Fisher mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.1.3 Thermo Fisher mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Thermo Fisher Main Business Overview
13.1.5 Thermo Fisher Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.2.3 Merck mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Qiagen N.V.
13.3.1 Qiagen N.V. Company Information
13.3.2 Qiagen N.V. mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.3.3 Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Qiagen N.V. Main Business Overview
13.3.5 Qiagen N.V. Latest Developments
13.4 CureVac
13.4.1 CureVac Company Information
13.4.2 CureVac mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.4.3 CureVac mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 CureVac Main Business Overview
13.4.5 CureVac Latest Developments
13.5 In-Cell-Art
13.5.1 In-Cell-Art Company Information
13.5.2 In-Cell-Art mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.5.3 In-Cell-Art mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 In-Cell-Art Main Business Overview
13.5.5 In-Cell-Art Latest Developments
13.6 eTheRNA
13.6.1 eTheRNA Company Information
13.6.2 eTheRNA mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.6.3 eTheRNA mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 eTheRNA Main Business Overview
13.6.5 eTheRNA Latest Developments
13.7 Takara Bio Inc.
13.7.1 Takara Bio Inc. Company Information
13.7.2 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.7.3 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Takara Bio Inc. Main Business Overview
13.7.5 Takara Bio Inc. Latest Developments
13.8 Sangamo Therapeutics
13.8.1 Sangamo Therapeutics Company Information
13.8.2 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.8.3 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sangamo Therapeutics Main Business Overview
13.8.5 Sangamo Therapeutics Latest Developments
13.9 Roche CustomBiotech
13.9.1 Roche CustomBiotech Company Information
13.9.2 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.9.3 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Roche CustomBiotech Main Business Overview
13.9.5 Roche CustomBiotech Latest Developments
13.10 BioNTech
13.10.1 BioNTech Company Information
13.10.2 BioNTech mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.10.3 BioNTech mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 BioNTech Main Business Overview
13.10.5 BioNTech Latest Developments
13.11 Tiba Biotechnology
13.11.1 Tiba Biotechnology Company Information
13.11.2 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.11.3 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Tiba Biotechnology Main Business Overview
13.11.5 Tiba Biotechnology Latest Developments
13.12 TriLink Bio Technologies
13.12.1 TriLink Bio Technologies Company Information
13.12.2 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.12.3 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 TriLink Bio Technologies Main Business Overview
13.12.5 TriLink Bio Technologies Latest Developments
13.13 Argos Therapeutics
13.13.1 Argos Therapeutics Company Information
13.13.2 Argos Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.13.3 Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Argos Therapeutics Main Business Overview
13.13.5 Argos Therapeutics Latest Developments
13.14 Moderna Therapeutics
13.14.1 Moderna Therapeutics Company Information
13.14.2 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.14.3 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Moderna Therapeutics Main Business Overview
13.14.5 Moderna Therapeutics Latest Developments
13.15 NEB
13.15.1 NEB Company Information
13.15.2 NEB mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.15.3 NEB mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 NEB Main Business Overview
13.15.5 NEB Latest Developments
13.16 Ethris
13.16.1 Ethris Company Information
13.16.2 Ethris mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.16.3 Ethris mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Ethris Main Business Overview
13.16.5 Ethris Latest Developments
13.17 Aldevron
13.17.1 Aldevron Company Information
13.17.2 Aldevron mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.17.3 Aldevron mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Aldevron Main Business Overview
13.17.5 Aldevron Latest Developments
13.18 Promega
13.18.1 Promega Company Information
13.18.2 Promega mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.18.3 Promega mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Promega Main Business Overview
13.18.5 Promega Latest Developments
13.19 Translate Bio
13.19.1 Translate Bio Company Information
13.19.2 Translate Bio mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.19.3 Translate Bio mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Translate Bio Main Business Overview
13.19.5 Translate Bio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global mRNA Vaccines and mRNA Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for mRNA Vaccines and mRNA Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for mRNA Vaccines and mRNA Drugs by Country/Region, 2018, 2022 & 2029
2.2 mRNA Vaccines and mRNA Drugs Segment by Type
2.2.1 Vaccine
2.2.2 API
2.3 mRNA Vaccines and mRNA Drugs Sales by Type
2.3.1 Global mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global mRNA Vaccines and mRNA Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global mRNA Vaccines and mRNA Drugs Sale Price by Type (2018-2023)
2.4 mRNA Vaccines and mRNA Drugs Segment by Application
2.4.1 Infectious Disease
2.4.2 Cancer
2.5 mRNA Vaccines and mRNA Drugs Sales by Application
2.5.1 Global mRNA Vaccines and mRNA Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global mRNA Vaccines and mRNA Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global mRNA Vaccines and mRNA Drugs Sale Price by Application (2018-2023)
3 GLOBAL MRNA VACCINES AND MRNA DRUGS BY COMPANY
3.1 Global mRNA Vaccines and mRNA Drugs Breakdown Data by Company
3.1.1 Global mRNA Vaccines and mRNA Drugs Annual Sales by Company (2018-2023)
3.1.2 Global mRNA Vaccines and mRNA Drugs Sales Market Share by Company (2018-2023)
3.2 Global mRNA Vaccines and mRNA Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global mRNA Vaccines and mRNA Drugs Revenue by Company (2018-2023)
3.2.2 Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Company (2018-2023)
3.3 Global mRNA Vaccines and mRNA Drugs Sale Price by Company
3.4 Key Manufacturers mRNA Vaccines and mRNA Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers mRNA Vaccines and mRNA Drugs Product Location Distribution
3.4.2 Players mRNA Vaccines and mRNA Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MRNA VACCINES AND MRNA DRUGS BY GEOGRAPHIC REGION
4.1 World Historic mRNA Vaccines and mRNA Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global mRNA Vaccines and mRNA Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global mRNA Vaccines and mRNA Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic mRNA Vaccines and mRNA Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global mRNA Vaccines and mRNA Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global mRNA Vaccines and mRNA Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas mRNA Vaccines and mRNA Drugs Sales Growth
4.4 APAC mRNA Vaccines and mRNA Drugs Sales Growth
4.5 Europe mRNA Vaccines and mRNA Drugs Sales Growth
4.6 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Growth
5 AMERICAS
5.1 Americas mRNA Vaccines and mRNA Drugs Sales by Country
5.1.1 Americas mRNA Vaccines and mRNA Drugs Sales by Country (2018-2023)
5.1.2 Americas mRNA Vaccines and mRNA Drugs Revenue by Country (2018-2023)
5.2 Americas mRNA Vaccines and mRNA Drugs Sales by Type
5.3 Americas mRNA Vaccines and mRNA Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Vaccines and mRNA Drugs Sales by Region
6.1.1 APAC mRNA Vaccines and mRNA Drugs Sales by Region (2018-2023)
6.1.2 APAC mRNA Vaccines and mRNA Drugs Revenue by Region (2018-2023)
6.2 APAC mRNA Vaccines and mRNA Drugs Sales by Type
6.3 APAC mRNA Vaccines and mRNA Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe mRNA Vaccines and mRNA Drugs by Country
7.1.1 Europe mRNA Vaccines and mRNA Drugs Sales by Country (2018-2023)
7.1.2 Europe mRNA Vaccines and mRNA Drugs Revenue by Country (2018-2023)
7.2 Europe mRNA Vaccines and mRNA Drugs Sales by Type
7.3 Europe mRNA Vaccines and mRNA Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa mRNA Vaccines and mRNA Drugs by Country
8.1.1 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Type
8.3 Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of mRNA Vaccines and mRNA Drugs
10.3 Manufacturing Process Analysis of mRNA Vaccines and mRNA Drugs
10.4 Industry Chain Structure of mRNA Vaccines and mRNA Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 mRNA Vaccines and mRNA Drugs Distributors
11.3 mRNA Vaccines and mRNA Drugs Customer
12 WORLD FORECAST REVIEW FOR MRNA VACCINES AND MRNA DRUGS BY GEOGRAPHIC REGION
12.1 Global mRNA Vaccines and mRNA Drugs Market Size Forecast by Region
12.1.1 Global mRNA Vaccines and mRNA Drugs Forecast by Region (2024-2029)
12.1.2 Global mRNA Vaccines and mRNA Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global mRNA Vaccines and mRNA Drugs Forecast by Type
12.7 Global mRNA Vaccines and mRNA Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher
13.1.1 Thermo Fisher Company Information
13.1.2 Thermo Fisher mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.1.3 Thermo Fisher mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Thermo Fisher Main Business Overview
13.1.5 Thermo Fisher Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.2.3 Merck mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Qiagen N.V.
13.3.1 Qiagen N.V. Company Information
13.3.2 Qiagen N.V. mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.3.3 Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Qiagen N.V. Main Business Overview
13.3.5 Qiagen N.V. Latest Developments
13.4 CureVac
13.4.1 CureVac Company Information
13.4.2 CureVac mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.4.3 CureVac mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 CureVac Main Business Overview
13.4.5 CureVac Latest Developments
13.5 In-Cell-Art
13.5.1 In-Cell-Art Company Information
13.5.2 In-Cell-Art mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.5.3 In-Cell-Art mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 In-Cell-Art Main Business Overview
13.5.5 In-Cell-Art Latest Developments
13.6 eTheRNA
13.6.1 eTheRNA Company Information
13.6.2 eTheRNA mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.6.3 eTheRNA mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 eTheRNA Main Business Overview
13.6.5 eTheRNA Latest Developments
13.7 Takara Bio Inc.
13.7.1 Takara Bio Inc. Company Information
13.7.2 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.7.3 Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Takara Bio Inc. Main Business Overview
13.7.5 Takara Bio Inc. Latest Developments
13.8 Sangamo Therapeutics
13.8.1 Sangamo Therapeutics Company Information
13.8.2 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.8.3 Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sangamo Therapeutics Main Business Overview
13.8.5 Sangamo Therapeutics Latest Developments
13.9 Roche CustomBiotech
13.9.1 Roche CustomBiotech Company Information
13.9.2 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.9.3 Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Roche CustomBiotech Main Business Overview
13.9.5 Roche CustomBiotech Latest Developments
13.10 BioNTech
13.10.1 BioNTech Company Information
13.10.2 BioNTech mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.10.3 BioNTech mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 BioNTech Main Business Overview
13.10.5 BioNTech Latest Developments
13.11 Tiba Biotechnology
13.11.1 Tiba Biotechnology Company Information
13.11.2 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.11.3 Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Tiba Biotechnology Main Business Overview
13.11.5 Tiba Biotechnology Latest Developments
13.12 TriLink Bio Technologies
13.12.1 TriLink Bio Technologies Company Information
13.12.2 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.12.3 TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 TriLink Bio Technologies Main Business Overview
13.12.5 TriLink Bio Technologies Latest Developments
13.13 Argos Therapeutics
13.13.1 Argos Therapeutics Company Information
13.13.2 Argos Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.13.3 Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Argos Therapeutics Main Business Overview
13.13.5 Argos Therapeutics Latest Developments
13.14 Moderna Therapeutics
13.14.1 Moderna Therapeutics Company Information
13.14.2 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.14.3 Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Moderna Therapeutics Main Business Overview
13.14.5 Moderna Therapeutics Latest Developments
13.15 NEB
13.15.1 NEB Company Information
13.15.2 NEB mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.15.3 NEB mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 NEB Main Business Overview
13.15.5 NEB Latest Developments
13.16 Ethris
13.16.1 Ethris Company Information
13.16.2 Ethris mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.16.3 Ethris mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Ethris Main Business Overview
13.16.5 Ethris Latest Developments
13.17 Aldevron
13.17.1 Aldevron Company Information
13.17.2 Aldevron mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.17.3 Aldevron mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Aldevron Main Business Overview
13.17.5 Aldevron Latest Developments
13.18 Promega
13.18.1 Promega Company Information
13.18.2 Promega mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.18.3 Promega mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Promega Main Business Overview
13.18.5 Promega Latest Developments
13.19 Translate Bio
13.19.1 Translate Bio Company Information
13.19.2 Translate Bio mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
13.19.3 Translate Bio mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Translate Bio Main Business Overview
13.19.5 Translate Bio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. mRNA Vaccines and mRNA Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. mRNA Vaccines and mRNA Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Vaccine
Table 4. Major Players of API
Table 5. Global mRNA Vaccines and mRNA Drugs Sales by Type (2018-2023) & (K Units)
Table 6. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2018-2023)
Table 7. Global mRNA Vaccines and mRNA Drugs Revenue by Type (2018-2023) & ($ million)
Table 8. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Type (2018-2023)
Table 9. Global mRNA Vaccines and mRNA Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global mRNA Vaccines and mRNA Drugs Sales by Application (2018-2023) & (K Units)
Table 11. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2018-2023)
Table 12. Global mRNA Vaccines and mRNA Drugs Revenue by Application (2018-2023)
Table 13. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Application (2018-2023)
Table 14. Global mRNA Vaccines and mRNA Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global mRNA Vaccines and mRNA Drugs Sales by Company (2018-2023) & (K Units)
Table 16. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Company (2018-2023)
Table 17. Global mRNA Vaccines and mRNA Drugs Revenue by Company (2018-2023) ($ Millions)
Table 18. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Company (2018-2023)
Table 19. Global mRNA Vaccines and mRNA Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers mRNA Vaccines and mRNA Drugs Producing Area Distribution and Sales Area
Table 21. Players mRNA Vaccines and mRNA Drugs Products Offered
Table 22. mRNA Vaccines and mRNA Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global mRNA Vaccines and mRNA Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global mRNA Vaccines and mRNA Drugs Sales Market Share Geographic Region (2018-2023)
Table 27. Global mRNA Vaccines and mRNA Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global mRNA Vaccines and mRNA Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Country/Region (2018-2023)
Table 31. Global mRNA Vaccines and mRNA Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas mRNA Vaccines and mRNA Drugs Sales by Country (2018-2023) & (K Units)
Table 34. Americas mRNA Vaccines and mRNA Drugs Sales Market Share by Country (2018-2023)
Table 35. Americas mRNA Vaccines and mRNA Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas mRNA Vaccines and mRNA Drugs Revenue Market Share by Country (2018-2023)
Table 37. Americas mRNA Vaccines and mRNA Drugs Sales by Type (2018-2023) & (K Units)
Table 38. Americas mRNA Vaccines and mRNA Drugs Sales by Application (2018-2023) & (K Units)
Table 39. APAC mRNA Vaccines and mRNA Drugs Sales by Region (2018-2023) & (K Units)
Table 40. APAC mRNA Vaccines and mRNA Drugs Sales Market Share by Region (2018-2023)
Table 41. APAC mRNA Vaccines and mRNA Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC mRNA Vaccines and mRNA Drugs Revenue Market Share by Region (2018-2023)
Table 43. APAC mRNA Vaccines and mRNA Drugs Sales by Type (2018-2023) & (K Units)
Table 44. APAC mRNA Vaccines and mRNA Drugs Sales by Application (2018-2023) & (K Units)
Table 45. Europe mRNA Vaccines and mRNA Drugs Sales by Country (2018-2023) & (K Units)
Table 46. Europe mRNA Vaccines and mRNA Drugs Sales Market Share by Country (2018-2023)
Table 47. Europe mRNA Vaccines and mRNA Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe mRNA Vaccines and mRNA Drugs Revenue Market Share by Country (2018-2023)
Table 49. Europe mRNA Vaccines and mRNA Drugs Sales by Type (2018-2023) & (K Units)
Table 50. Europe mRNA Vaccines and mRNA Drugs Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of mRNA Vaccines and mRNA Drugs
Table 58. Key Market Challenges & Risks of mRNA Vaccines and mRNA Drugs
Table 59. Key Industry Trends of mRNA Vaccines and mRNA Drugs
Table 60. mRNA Vaccines and mRNA Drugs Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. mRNA Vaccines and mRNA Drugs Distributors List
Table 63. mRNA Vaccines and mRNA Drugs Customer List
Table 64. Global mRNA Vaccines and mRNA Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global mRNA Vaccines and mRNA Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas mRNA Vaccines and mRNA Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas mRNA Vaccines and mRNA Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC mRNA Vaccines and mRNA Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC mRNA Vaccines and mRNA Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe mRNA Vaccines and mRNA Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe mRNA Vaccines and mRNA Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global mRNA Vaccines and mRNA Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global mRNA Vaccines and mRNA Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global mRNA Vaccines and mRNA Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global mRNA Vaccines and mRNA Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Thermo Fisher Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Thermo Fisher mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 80. Thermo Fisher mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Thermo Fisher Main Business
Table 82. Thermo Fisher Latest Developments
Table 83. Merck Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 85. Merck mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Qiagen N.V. Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Qiagen N.V. mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 90. Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Qiagen N.V. Main Business
Table 92. Qiagen N.V. Latest Developments
Table 93. CureVac Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. CureVac mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 95. CureVac mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. CureVac Main Business
Table 97. CureVac Latest Developments
Table 98. In-Cell-Art Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. In-Cell-Art mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 100. In-Cell-Art mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. In-Cell-Art Main Business
Table 102. In-Cell-Art Latest Developments
Table 103. eTheRNA Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. eTheRNA mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 105. eTheRNA mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. eTheRNA Main Business
Table 107. eTheRNA Latest Developments
Table 108. Takara Bio Inc. Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 110. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Takara Bio Inc. Main Business
Table 112. Takara Bio Inc. Latest Developments
Table 113. Sangamo Therapeutics Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 115. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Sangamo Therapeutics Main Business
Table 117. Sangamo Therapeutics Latest Developments
Table 118. Roche CustomBiotech Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 120. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Roche CustomBiotech Main Business
Table 122. Roche CustomBiotech Latest Developments
Table 123. BioNTech Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. BioNTech mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 125. BioNTech mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. BioNTech Main Business
Table 127. BioNTech Latest Developments
Table 128. Tiba Biotechnology Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 130. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Tiba Biotechnology Main Business
Table 132. Tiba Biotechnology Latest Developments
Table 133. TriLink Bio Technologies Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 135. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. TriLink Bio Technologies Main Business
Table 137. TriLink Bio Technologies Latest Developments
Table 138. Argos Therapeutics Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 139. Argos Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 140. Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Argos Therapeutics Main Business
Table 142. Argos Therapeutics Latest Developments
Table 143. Moderna Therapeutics Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 144. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 145. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Moderna Therapeutics Main Business
Table 147. Moderna Therapeutics Latest Developments
Table 148. NEB Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 149. NEB mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 150. NEB mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. NEB Main Business
Table 152. NEB Latest Developments
Table 153. Ethris Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 154. Ethris mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 155. Ethris mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Ethris Main Business
Table 157. Ethris Latest Developments
Table 158. Aldevron Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 159. Aldevron mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 160. Aldevron mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Aldevron Main Business
Table 162. Aldevron Latest Developments
Table 163. Promega Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 164. Promega mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 165. Promega mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Promega Main Business
Table 167. Promega Latest Developments
Table 168. Translate Bio Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 169. Translate Bio mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 170. Translate Bio mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Translate Bio Main Business
Table 172. Translate Bio Latest Developments
Table 1. mRNA Vaccines and mRNA Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. mRNA Vaccines and mRNA Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Vaccine
Table 4. Major Players of API
Table 5. Global mRNA Vaccines and mRNA Drugs Sales by Type (2018-2023) & (K Units)
Table 6. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2018-2023)
Table 7. Global mRNA Vaccines and mRNA Drugs Revenue by Type (2018-2023) & ($ million)
Table 8. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Type (2018-2023)
Table 9. Global mRNA Vaccines and mRNA Drugs Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global mRNA Vaccines and mRNA Drugs Sales by Application (2018-2023) & (K Units)
Table 11. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2018-2023)
Table 12. Global mRNA Vaccines and mRNA Drugs Revenue by Application (2018-2023)
Table 13. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Application (2018-2023)
Table 14. Global mRNA Vaccines and mRNA Drugs Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global mRNA Vaccines and mRNA Drugs Sales by Company (2018-2023) & (K Units)
Table 16. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Company (2018-2023)
Table 17. Global mRNA Vaccines and mRNA Drugs Revenue by Company (2018-2023) ($ Millions)
Table 18. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Company (2018-2023)
Table 19. Global mRNA Vaccines and mRNA Drugs Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers mRNA Vaccines and mRNA Drugs Producing Area Distribution and Sales Area
Table 21. Players mRNA Vaccines and mRNA Drugs Products Offered
Table 22. mRNA Vaccines and mRNA Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global mRNA Vaccines and mRNA Drugs Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global mRNA Vaccines and mRNA Drugs Sales Market Share Geographic Region (2018-2023)
Table 27. Global mRNA Vaccines and mRNA Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global mRNA Vaccines and mRNA Drugs Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Country/Region (2018-2023)
Table 31. Global mRNA Vaccines and mRNA Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas mRNA Vaccines and mRNA Drugs Sales by Country (2018-2023) & (K Units)
Table 34. Americas mRNA Vaccines and mRNA Drugs Sales Market Share by Country (2018-2023)
Table 35. Americas mRNA Vaccines and mRNA Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas mRNA Vaccines and mRNA Drugs Revenue Market Share by Country (2018-2023)
Table 37. Americas mRNA Vaccines and mRNA Drugs Sales by Type (2018-2023) & (K Units)
Table 38. Americas mRNA Vaccines and mRNA Drugs Sales by Application (2018-2023) & (K Units)
Table 39. APAC mRNA Vaccines and mRNA Drugs Sales by Region (2018-2023) & (K Units)
Table 40. APAC mRNA Vaccines and mRNA Drugs Sales Market Share by Region (2018-2023)
Table 41. APAC mRNA Vaccines and mRNA Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC mRNA Vaccines and mRNA Drugs Revenue Market Share by Region (2018-2023)
Table 43. APAC mRNA Vaccines and mRNA Drugs Sales by Type (2018-2023) & (K Units)
Table 44. APAC mRNA Vaccines and mRNA Drugs Sales by Application (2018-2023) & (K Units)
Table 45. Europe mRNA Vaccines and mRNA Drugs Sales by Country (2018-2023) & (K Units)
Table 46. Europe mRNA Vaccines and mRNA Drugs Sales Market Share by Country (2018-2023)
Table 47. Europe mRNA Vaccines and mRNA Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe mRNA Vaccines and mRNA Drugs Revenue Market Share by Country (2018-2023)
Table 49. Europe mRNA Vaccines and mRNA Drugs Sales by Type (2018-2023) & (K Units)
Table 50. Europe mRNA Vaccines and mRNA Drugs Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of mRNA Vaccines and mRNA Drugs
Table 58. Key Market Challenges & Risks of mRNA Vaccines and mRNA Drugs
Table 59. Key Industry Trends of mRNA Vaccines and mRNA Drugs
Table 60. mRNA Vaccines and mRNA Drugs Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. mRNA Vaccines and mRNA Drugs Distributors List
Table 63. mRNA Vaccines and mRNA Drugs Customer List
Table 64. Global mRNA Vaccines and mRNA Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global mRNA Vaccines and mRNA Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas mRNA Vaccines and mRNA Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas mRNA Vaccines and mRNA Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC mRNA Vaccines and mRNA Drugs Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC mRNA Vaccines and mRNA Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe mRNA Vaccines and mRNA Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe mRNA Vaccines and mRNA Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global mRNA Vaccines and mRNA Drugs Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global mRNA Vaccines and mRNA Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global mRNA Vaccines and mRNA Drugs Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global mRNA Vaccines and mRNA Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Thermo Fisher Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Thermo Fisher mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 80. Thermo Fisher mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Thermo Fisher Main Business
Table 82. Thermo Fisher Latest Developments
Table 83. Merck Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 85. Merck mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Qiagen N.V. Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Qiagen N.V. mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 90. Qiagen N.V. mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Qiagen N.V. Main Business
Table 92. Qiagen N.V. Latest Developments
Table 93. CureVac Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. CureVac mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 95. CureVac mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. CureVac Main Business
Table 97. CureVac Latest Developments
Table 98. In-Cell-Art Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. In-Cell-Art mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 100. In-Cell-Art mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. In-Cell-Art Main Business
Table 102. In-Cell-Art Latest Developments
Table 103. eTheRNA Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. eTheRNA mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 105. eTheRNA mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. eTheRNA Main Business
Table 107. eTheRNA Latest Developments
Table 108. Takara Bio Inc. Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 110. Takara Bio Inc. mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Takara Bio Inc. Main Business
Table 112. Takara Bio Inc. Latest Developments
Table 113. Sangamo Therapeutics Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 115. Sangamo Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Sangamo Therapeutics Main Business
Table 117. Sangamo Therapeutics Latest Developments
Table 118. Roche CustomBiotech Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 120. Roche CustomBiotech mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Roche CustomBiotech Main Business
Table 122. Roche CustomBiotech Latest Developments
Table 123. BioNTech Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. BioNTech mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 125. BioNTech mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. BioNTech Main Business
Table 127. BioNTech Latest Developments
Table 128. Tiba Biotechnology Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 130. Tiba Biotechnology mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Tiba Biotechnology Main Business
Table 132. Tiba Biotechnology Latest Developments
Table 133. TriLink Bio Technologies Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 135. TriLink Bio Technologies mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. TriLink Bio Technologies Main Business
Table 137. TriLink Bio Technologies Latest Developments
Table 138. Argos Therapeutics Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 139. Argos Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 140. Argos Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Argos Therapeutics Main Business
Table 142. Argos Therapeutics Latest Developments
Table 143. Moderna Therapeutics Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 144. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 145. Moderna Therapeutics mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Moderna Therapeutics Main Business
Table 147. Moderna Therapeutics Latest Developments
Table 148. NEB Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 149. NEB mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 150. NEB mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. NEB Main Business
Table 152. NEB Latest Developments
Table 153. Ethris Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 154. Ethris mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 155. Ethris mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Ethris Main Business
Table 157. Ethris Latest Developments
Table 158. Aldevron Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 159. Aldevron mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 160. Aldevron mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Aldevron Main Business
Table 162. Aldevron Latest Developments
Table 163. Promega Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 164. Promega mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 165. Promega mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Promega Main Business
Table 167. Promega Latest Developments
Table 168. Translate Bio Basic Information, mRNA Vaccines and mRNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 169. Translate Bio mRNA Vaccines and mRNA Drugs Product Portfolios and Specifications
Table 170. Translate Bio mRNA Vaccines and mRNA Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Translate Bio Main Business
Table 172. Translate Bio Latest Developments
LIST OF FIGURES
Figure 1. Picture of mRNA Vaccines and mRNA Drugs
Figure 2. mRNA Vaccines and mRNA Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA Vaccines and mRNA Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global mRNA Vaccines and mRNA Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. mRNA Vaccines and mRNA Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Vaccine
Figure 10. Product Picture of API
Figure 11. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Type in 2022
Figure 12. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Type (2018-2023)
Figure 13. mRNA Vaccines and mRNA Drugs Consumed in Infectious Disease
Figure 14. Global mRNA Vaccines and mRNA Drugs Market: Infectious Disease (2018-2023) & (K Units)
Figure 15. mRNA Vaccines and mRNA Drugs Consumed in Cancer
Figure 16. Global mRNA Vaccines and mRNA Drugs Market: Cancer (2018-2023) & (K Units)
Figure 17. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2022)
Figure 18. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Application in 2022
Figure 19. mRNA Vaccines and mRNA Drugs Sales Market by Company in 2022 (K Units)
Figure 20. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Company in 2022
Figure 21. mRNA Vaccines and mRNA Drugs Revenue Market by Company in 2022 ($ Million)
Figure 22. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Company in 2022
Figure 23. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Geographic Region in 2022
Figure 25. Americas mRNA Vaccines and mRNA Drugs Sales 2018-2023 (K Units)
Figure 26. Americas mRNA Vaccines and mRNA Drugs Revenue 2018-2023 ($ Millions)
Figure 27. APAC mRNA Vaccines and mRNA Drugs Sales 2018-2023 (K Units)
Figure 28. APAC mRNA Vaccines and mRNA Drugs Revenue 2018-2023 ($ Millions)
Figure 29. Europe mRNA Vaccines and mRNA Drugs Sales 2018-2023 (K Units)
Figure 30. Europe mRNA Vaccines and mRNA Drugs Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue 2018-2023 ($ Millions)
Figure 33. Americas mRNA Vaccines and mRNA Drugs Sales Market Share by Country in 2022
Figure 34. Americas mRNA Vaccines and mRNA Drugs Revenue Market Share by Country in 2022
Figure 35. Americas mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2018-2023)
Figure 36. Americas mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2018-2023)
Figure 37. United States mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC mRNA Vaccines and mRNA Drugs Sales Market Share by Region in 2022
Figure 42. APAC mRNA Vaccines and mRNA Drugs Revenue Market Share by Regions in 2022
Figure 43. APAC mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2018-2023)
Figure 44. APAC mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2018-2023)
Figure 45. China mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. India mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe mRNA Vaccines and mRNA Drugs Sales Market Share by Country in 2022
Figure 53. Europe mRNA Vaccines and mRNA Drugs Revenue Market Share by Country in 2022
Figure 54. Europe mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2018-2023)
Figure 55. Europe mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2018-2023)
Figure 56. Germany mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. France mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Market Share by Country in 2022
Figure 62. Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2018-2023)
Figure 65. Egypt mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of mRNA Vaccines and mRNA Drugs in 2022
Figure 71. Manufacturing Process Analysis of mRNA Vaccines and mRNA Drugs
Figure 72. Industry Chain Structure of mRNA Vaccines and mRNA Drugs
Figure 73. Channels of Distribution
Figure 74. Global mRNA Vaccines and mRNA Drugs Sales Market Forecast by Region (2024-2029)
Figure 75. Global mRNA Vaccines and mRNA Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global mRNA Vaccines and mRNA Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global mRNA Vaccines and mRNA Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global mRNA Vaccines and mRNA Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global mRNA Vaccines and mRNA Drugs Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of mRNA Vaccines and mRNA Drugs
Figure 2. mRNA Vaccines and mRNA Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA Vaccines and mRNA Drugs Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global mRNA Vaccines and mRNA Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. mRNA Vaccines and mRNA Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Vaccine
Figure 10. Product Picture of API
Figure 11. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Type in 2022
Figure 12. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Type (2018-2023)
Figure 13. mRNA Vaccines and mRNA Drugs Consumed in Infectious Disease
Figure 14. Global mRNA Vaccines and mRNA Drugs Market: Infectious Disease (2018-2023) & (K Units)
Figure 15. mRNA Vaccines and mRNA Drugs Consumed in Cancer
Figure 16. Global mRNA Vaccines and mRNA Drugs Market: Cancer (2018-2023) & (K Units)
Figure 17. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2022)
Figure 18. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Application in 2022
Figure 19. mRNA Vaccines and mRNA Drugs Sales Market by Company in 2022 (K Units)
Figure 20. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Company in 2022
Figure 21. mRNA Vaccines and mRNA Drugs Revenue Market by Company in 2022 ($ Million)
Figure 22. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Company in 2022
Figure 23. Global mRNA Vaccines and mRNA Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global mRNA Vaccines and mRNA Drugs Revenue Market Share by Geographic Region in 2022
Figure 25. Americas mRNA Vaccines and mRNA Drugs Sales 2018-2023 (K Units)
Figure 26. Americas mRNA Vaccines and mRNA Drugs Revenue 2018-2023 ($ Millions)
Figure 27. APAC mRNA Vaccines and mRNA Drugs Sales 2018-2023 (K Units)
Figure 28. APAC mRNA Vaccines and mRNA Drugs Revenue 2018-2023 ($ Millions)
Figure 29. Europe mRNA Vaccines and mRNA Drugs Sales 2018-2023 (K Units)
Figure 30. Europe mRNA Vaccines and mRNA Drugs Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue 2018-2023 ($ Millions)
Figure 33. Americas mRNA Vaccines and mRNA Drugs Sales Market Share by Country in 2022
Figure 34. Americas mRNA Vaccines and mRNA Drugs Revenue Market Share by Country in 2022
Figure 35. Americas mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2018-2023)
Figure 36. Americas mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2018-2023)
Figure 37. United States mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC mRNA Vaccines and mRNA Drugs Sales Market Share by Region in 2022
Figure 42. APAC mRNA Vaccines and mRNA Drugs Revenue Market Share by Regions in 2022
Figure 43. APAC mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2018-2023)
Figure 44. APAC mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2018-2023)
Figure 45. China mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. India mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe mRNA Vaccines and mRNA Drugs Sales Market Share by Country in 2022
Figure 53. Europe mRNA Vaccines and mRNA Drugs Revenue Market Share by Country in 2022
Figure 54. Europe mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2018-2023)
Figure 55. Europe mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2018-2023)
Figure 56. Germany mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 57. France mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Market Share by Country in 2022
Figure 62. Middle East & Africa mRNA Vaccines and mRNA Drugs Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa mRNA Vaccines and mRNA Drugs Sales Market Share by Application (2018-2023)
Figure 65. Egypt mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country mRNA Vaccines and mRNA Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of mRNA Vaccines and mRNA Drugs in 2022
Figure 71. Manufacturing Process Analysis of mRNA Vaccines and mRNA Drugs
Figure 72. Industry Chain Structure of mRNA Vaccines and mRNA Drugs
Figure 73. Channels of Distribution
Figure 74. Global mRNA Vaccines and mRNA Drugs Sales Market Forecast by Region (2024-2029)
Figure 75. Global mRNA Vaccines and mRNA Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global mRNA Vaccines and mRNA Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global mRNA Vaccines and mRNA Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global mRNA Vaccines and mRNA Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global mRNA Vaccines and mRNA Drugs Revenue Market Share Forecast by Application (2024-2029)
